TCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III November 28, 2014
TCL Archive Legal experts say too many conflicts involved. HHS gave von Eschenbach a waiver for his role in C-Change. September 30, 2005
TCL Archive In Brief: Pay raise Must Come From Intramural Funds, Not Extramural, Administration Says May 9, 1980
TCL Archive House Preserves Funds For Space Station; Cancer Societies Reiterate Support For $170 Million Increase For NCI August 7, 1992
TCL Archive Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer February 29, 2008
